The preparation "Bromocriptine": the instruction

The medicine "Bromocriptine", instruction for use indicates, is released in the form of tablets of 2.5 mg. The active substance is bromocriptine mesylate.

The drug belongs to the clinical and pharmacological group of inhibitors of prolactin secretion. Pharmacological action is based on the ability of the drug "Bromocriptine" to improve the work of dopamine receptors and inhibit the synthesis of prolactin in the body. As a result, the process of physiological lactation stops and the menstrual cycle is normalized.

The drug "Bromocriptine", the instruction indicates, provides a balance of the hormonal level, a balance between progesterone and estrogens. This makes it possible to eliminate cysts formed in the mammary gland, at least to reduce their size. The drug is not associated with a risk of developing thromboembolism or postpartum involution of the uterus. Tablets are taken to adjust the body's production of luteinizing hormone and to reduce the manifestation of polycystic ovaries.

Under the action of the drug, the growth of pituitary adenoma, which produces prolactin, stops, its size decreases. High doses of bromocriptine are capable of restoring the neurochemical equilibrium in the organs of the brain, stimulating their work.

The medication "Bromocriptine", the instruction indicates, significantly improves the condition of patients with Parkinson's syndrome. It blocks tremors and stiffness, activates movements at all stages of the development of the diagnosis. In addition, the drug eliminates the symptoms of depression that occurs against the background of Parkinson's disease.

The active substance inhibits the production of such pituitary hormones as somatotropic and adrenocorticotropic, but at the same time does not affect the synthesis of other hormones.

The drug "Bromocriptine". Instructions. Indications

The doctor prescribes the drug in the following cases:

• With violations of the menstrual cycle;
• With established diagnoses associated with prolactin dependence;
• With amenorrhea, including complicated galactorrhea;
• With female infertility;
• With oligomenorrhea;
• With insufficiency of the luteal phase;
• With hyperprolactinemia of secondary type, developed against the background of long-term use of certain drugs;
• With female infertility, not associated with prolactin dependence;
• With polycystic ovaries;
• At anovulatory cycles ;
• With premenstrual syndrome with tenderness of the mammary glands, edema, flatulence, mood swings;
• With hyperprolactinemia in men;
• With oligospermia, lack of libido, impotence;
• With prolactinomas of the pituitary gland;
• When preparing for surgery to reduce tumor volume;
• At rehabilitation after operations in those cases when the level of prolactin is elevated ;
• With acromegaly;
• For the suppression of lactation, including after an abortion;
• With thickening of the mammary glands after childbirth;
• Mastitis after childbirth;
• With diseases of the mammary glands;
• With mastalgia;
• With benign nodal or cystic changes;
• With Parkinson's disease in complex treatment or as a monotherapy.

The dosage of the drug is chosen by the doctor depending on the diagnosis and condition of the patient.

The drug "Bromocriptine", side effects

Disturbances in the digestive system are manifested by nausea, vomiting, dry mouth, constipation, diarrhea.

Disorders in the work of the cardiovascular system are manifested by hypotension, arrhythmia; Reinot's syndrome was observed in single patients as a result of prolonged use .

Violations in the work of the nervous system occur at the beginning of the course of treatment, are manifested by dizziness, headache, drowsiness, nervous arousal, dyskinesia, decreased vision, hallucinations.

Allergic reactions were observed only as a skin rash.

Very rarely mentioned nasal congestion, the cramps in the calf muscles.

The drug "Bromocriptine". Instructions. Contraindications

You can not prescribe the drug for arterial hypertension, tremor, Horering goutington, psychosis, cardiovascular disease, with hepatic insufficiency. Among the contraindications is also peptic ulcer of the gastrointestinal tract.

The drug is not intended for use in children under 15 years of age, pregnant women with toxicosis, patients with increased sensitivity to ergot derivatives. To produce the medicine "Bromocriptine" is used by an ergot.